Radioablative therapy with Iodine-131 on a patient with thyroid cancer and chronic renal failure in hemodialysis first experience in Peru

D. G. Apaza Veliz, R. D. Herrera Vera, C. A. Cardenas Abarca, C. A. Oporto Gonzales, C. Aguilar Ramírez, Jose Luis Javier Vega Ramirez, R. M. Urquizo Baldomero

Research output: Chapter in Book/Report/Conference proceedingConference contributionpeer-review

Abstract

The Iodine-131 (I-131) is a radioisotope used as a standard treatment for radioablation of thyroid remnants. Among thyroid cancer patients, the ones undergoing hemodialysis represent a specific group. The dose of I-131 is given orally to these patients, part of it is absorbed by the thyroid remnants and the rest of it, largely not incorporated, is excreted primarily by renal excretion. The use of a high dose of radioactivity in the process, and the inability of excretion, represents a high risk of exposure to the patient, medical staff and hemodialysis equipment. This work describes the procedure applied on the radioablation therapy for thyroid cancer while receiving hemodialysis, minimizing the risks for the patient and the staff involved. This clinical procedure will establish the dosimetric measures, a plan on radiation protection and a treatment protocol for this specific type of patients.

Original languageEnglish
Title of host publicationLatin American Symposium on Nuclear Physics and Applications, LASNPA 2015
EditorsFernando Cristancho
PublisherAmerican Institute of Physics Inc.
ISBN (Electronic)9780735414112
DOIs
StatePublished - 7 Jul 2016
Event11th Latin American Symposium on Nuclear Physics and Applications, LASNPA 2015 - Medellin, Colombia
Duration: 30 Nov 20154 Dec 2015

Publication series

NameAIP Conference Proceedings
Volume1753
ISSN (Print)0094-243X
ISSN (Electronic)1551-7616

Conference

Conference11th Latin American Symposium on Nuclear Physics and Applications, LASNPA 2015
Country/TerritoryColombia
CityMedellin
Period30/11/154/12/15

Bibliographical note

Publisher Copyright:
© 2016 Author(s).

Keywords

  • Dosimetry
  • Hemodialysis
  • Iodine-131
  • Radioablative Therapy
  • Radiology Protection

Fingerprint

Dive into the research topics of 'Radioablative therapy with Iodine-131 on a patient with thyroid cancer and chronic renal failure in hemodialysis first experience in Peru'. Together they form a unique fingerprint.

Cite this